|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/14 | (2006.01) |
| A61K 9/22 | (2006.01) | ||
| A61K 9/24 | (2006.01) |
| (11) | Number of the document | 2863891 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13730598.3 |
| Date of filing the European patent application | 2013-06-24 | |
| (97) | Date of publication of the European application | 2015-04-29 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-26 |
| (46) | Date of publication of the claims translation | 2020-12-10 |
| (86) | Number | PCT/EP2013/063163 |
| Date | 2013-06-24 |
| (87) | Number | WO 2014/001268 |
| Date | 2014-01-03 |
| (30) | Number | Date | Country code |
| 102012105512 | 2012-06-25 | DE |
| (72) |
FRANCAS, Gernot, DE
PRZYKLENK, Karl-Heinz, DE
|
| (73) |
Hennig Arzneimittel GmbH&Co. Kg,
Liebigstra e 1-2, 65439 Flörsheim am Main,
DE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Farmacinė forma, skirta veikliųjų medžiagų uždelstam atpalaidavimui |
| PHARMACEUTICAL FORM FOR EXTENDED RELEASE OF ACTIVE SUBSTANCES |
| Payment date | Validity (years) | Amount | |
| 2025-06-11 | 13 | 289.00 EUR |
| 2026-06-24 |